Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Healthstream (HSTM) Total Non-Current Liabilities (2016 - 2025)

Healthstream (HSTM) has disclosed Total Non-Current Liabilities for 16 consecutive years, with $158.4 million as the latest value for Q4 2025.

  • Quarterly Total Non-Current Liabilities rose 6.1% to $158.4 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $158.4 million through Dec 2025, up 6.1% year-over-year, with the annual reading at $158.4 million for FY2025, 6.1% up from the prior year.
  • Total Non-Current Liabilities for Q4 2025 was $158.4 million at Healthstream, up from $148.7 million in the prior quarter.
  • The five-year high for Total Non-Current Liabilities was $164.9 million in Q1 2023, with the low at $145.4 million in Q3 2024.
  • Average Total Non-Current Liabilities over 5 years is $153.9 million, with a median of $151.5 million recorded in 2021.
  • Peak annual rise in Total Non-Current Liabilities hit 11.61% in 2021, while the deepest fall reached 10.84% in 2021.
  • Over 5 years, Total Non-Current Liabilities stood at $146.3 million in 2021, then rose by 10.4% to $161.5 million in 2022, then fell by 2.82% to $156.9 million in 2023, then dropped by 4.84% to $149.3 million in 2024, then increased by 6.1% to $158.4 million in 2025.
  • According to Business Quant data, Total Non-Current Liabilities over the past three periods came in at $158.4 million, $148.7 million, and $147.6 million for Q4 2025, Q3 2025, and Q2 2025 respectively.